Evidence map›Paper›PMID 32849833›Full record

ArticleFrontiers in genetics2020

The Enigma of Low COVID-19 Fatality Rate in India.

Arghadip Samaddar, Ravisekhar Gadepalli, Vijaya Lakshmi Nag, Sanjeev Misra

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Academic Impact and Quality of Life Among Otorhinolaryngology Residents During COVID-19 Pandemic in South India.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. COVID-19 Pandemic in India: Through the Lens of Modeling.Global health, science and practice · 2021
    Article
  15. Article
  16. Molecular Basis of the Therapeutical Potential of Clove (Molecules (Basel, Switzerland) · 2021
    Review
  17. Observational
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arghadip SamaddarDepartment of Microbiology, All India Institute of Medical Sciences, Jodhpur, India.
Ravisekhar GadepalliDepartment of Microbiology, All India Institute of Medical Sciences, Jodhpur, India.
Vijaya Lakshmi NagDepartment of Microbiology, All India Institute of Medical Sciences, Jodhpur, India.
Sanjeev MisraDepartment of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India.
All India Institute of Medical Sciences Jodhpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel

Indexed as

angiotensin converting enzyme 2COVID-19Indian populationkiller cell immunoglobulin-like receptorsmicroRNASARS-CoV-2

Identifiers

PMID32849833
PMCPMC7399343
OpenAlexW3045578857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.